InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PepGen Inc.

PEPG Clue Score35
United States Fiscal year ends December CIK 0001835597
$2.62 +10.08% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.62 −46.53% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 6 May 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2021Operating income−27.1Net income−27.3EPS, diluted−30.27Fiscal year 2022Operating income−68.3Net income−69.1EPS, diluted−4.42Fiscal year 2023Operating income−84.8Net income−78.6EPS, diluted−3.30Fiscal year 2024Operating income−97.7Net income−90.0EPS, diluted−2.85Fiscal year 2025Operating income−93.6Net income−89.7EPS, diluted−2.12
FY2021FY2022FY2023FY2024FY2025
Operating income −27.1 −68.3 −84.8 −97.7 −93.6
Net income −27.3 −69.1 −78.6 −90.0 −89.7
Growth
EPS, diluted −30.27 −4.42 −3.30 −2.85 −2.12

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−22.6Capital expenditure−0.5Free cash flow−23.1Fiscal year 2022Operating cash flow−59.3Capital expenditure−3.8Free cash flow−63.0Fiscal year 2023Operating cash flow−69.0Capital expenditure−2.6Free cash flow−71.6Fiscal year 2024Operating cash flow−82.4Capital expenditure−0.5Free cash flow−82.9Fiscal year 2025Operating cash flow−81.6Capital expenditure−0.3Free cash flow−81.9
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −22.6 −59.3 −69.0 −82.4 −81.6
Capital expenditure −0.5 −3.8 −2.6 −0.5 −0.3
Free cash flow −23.1 −63.0 −71.6 −82.9 −81.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash132.9Shareholders’ equity−32.1Fiscal year 2022Cash181.8Shareholders’ equity179.6Fiscal year 2023Cash80.8Shareholders’ equity108.4Fiscal year 2024Cash49.4Shareholders’ equity118.6Fiscal year 2025Cash60.5Shareholders’ equity147.4
FY2021FY2022FY2023FY2024FY2025
Cash 132.9 181.8 80.8 49.4 60.5
Shareholders’ equity −32.1 179.6 108.4 118.6 147.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −38.5% −72.5% −75.9% −60.8%
−19.0% −31.8% −55.0% −59.6% −51.6%
Balance and payout
7.3% 17.4% 24.2% 21.4% 15.2%